Cleared Traditional

K162155 - Xario 200 Diagnostic Ultrasound System V5.0

K162155 is an FDA 510(k) clearance for Xario 200 Diagnostic Ultrasound System V5.0, manufactured by Toshibamedical Systems Corporation. The device is a Class 2 Radiology device with product code IYN cleared through the Traditional 510(k) pathway after a 91-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2016
Decision
91d
Days
Class 2
Risk

K162155 is an FDA 510(k) clearance for the Xario 200 Diagnostic Ultrasound System V5.0. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.

Submitted by Toshibamedical Systems Corporation (Otawara-Shi, JP). The FDA issued a Cleared decision on November 1, 2016 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Toshibamedical Systems Corporation devices

FDA 510(k) Submission Details - K162155

510(k) Number K162155 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 2016
Decision Date November 01, 2016
Days to Decision 91 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 107d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYN Device Classification - Class 2, Special Controls

Product Code IYN System, Imaging, Pulsed Doppler, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Toshiba America Medical Systems, In.C
ORLANDO TADEO

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IYN System, Imaging, Pulsed Doppler, Ultrasonic

All 1097
Devices cleared under the same product code (IYN) and FDA review panel - the closest regulatory comparables to K162155.
LOGIQ E9, LOGIQ E9 XDClear 2.0
K163077 · GE Medical Systems Ultrasound and Primary Care Diagnostics · Nov 2016
Aixplorer
K161999 · Supersonic Imagine · Nov 2016
Xperius Ultrasound System
K163020 · Philips Health Care · Nov 2016
Lucid M1 Transcranial Doppler Ultrasound System (Lucid M1 System) with 2MHz Transducers
K160442 · Neural Analytics, Inc. · Oct 2016
Ultrasound System SONIMAGE HS1
K162065 · Konica Minolta, Inc. · Oct 2016
NOBLUS™ Ultrasound Diagnostic System
K160559 · Hitachi Medical Corporation · Oct 2016